It’s almost that time of the year. Yes, the time for seasonal allergies. Seasonal allergies are commonly experienced during the spring, when trees and many other plants pollinate and its pollen becomes airborne. Although many people are overjoyed by the hint of warmer weather, others may not be so fond of spring. Those that are affected by seasonal allergies, a hypersensitive disorder of the immune system, may experience runny nose, watery eyes, sneezing, itchy eyes and nose…the list goes on. However, there are many treatment options available for seasonal allergies and among them is mometasone furoate nasal spray (MFNS). MFNS is a medication that is administered through the nose as a spray, and is well-established in managing allergic rhinitis (rhinitis: stuffy nose), one of the many symptoms of seasonal allergies. Not only is MFNS effective, but it’s also safe.
This sounds like an ideal medication for allergic rhinitis, right? Not necessarily, many people that suffer from allergic rhinitis also have a combination of other symptoms such as itchy and watery eyes. Furthermore, some people may not be so inclined towards using nasal sprays, maybe because it’s an uncomfortable or irritating way of administering a medication? Although MFNS may seem ideal, it helps manage one of the many symptoms allergy sufferers experience. Most people would opt for a more comprehensive medication, or one that would help manage most if not all of their symptoms.
But wait…there is more good news about MFNS. A recent study shows that MFNS also helps to reduce ocular symptoms (symptoms relating to the eyes) such as watery eyes and itchy eyes, in patients with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). SAR occurs during pollen seasons and PAR occurs throughout the year. Thus, this data suggests that MFNS may be an ideal, first-line therapy for those suffering from nasal and ocular allergy. It will not only provide symptom relief for both nasal and ocular allergy sufferers but there is also a low risk for systemic side effects.
But what if nasal sprays are not for you? What else is available? The Canadian Centre for Clinical Trials currently has two trials for allergies. One of the study medications, ToleroMune Ragweed, is administered as a shot and may one day be a treatment option for those suffering from Ragweed allergies. The other study medication, Dust Mite allergen extract, is a tablet administered sublingually (under the tongue) and may one day be a treatment option for those suffering from Dust Mite allergies. For more information or to see if you are eligible for any of our other trials, please click here.